2013 Tohyama S, Hattori F, Sano M, Hishiki T, Nagahata Y, Matsuura T, Yamashita H, Satoh Y, Hashimoto H, Egashira T, Seki T, Muraoka N, Yamakawa H, Ohgino Y, Yuasa S, Murata M, Suematsu M, Fukuda K.:Distinct metabokic flow enables large-scale purification of pluripotent stem cell-derived cardiomyocytes. Cell Stem  12(1):127-37 2013.
2012 Yokoyama K, Kojima T, Sakata Y, Kawasaki T, Tsuji H, Miyata T, Okamoto S, Murata M: A survey of the clinical course and management of Japanese patients deficient in natural anticoagulants. Clin Appl Thromb Hemost 18(5) pp506-513 2012.
2012 Ono Y, Wang Y, Suzuki H, Okamoto S, Ikeda Y, Murata M, Poncz M, Matsubara Y: Induction of functional platelets from mouse and human fibroblasts by p45NF-E2/Maf. Blood  Nov 1;120(18):3812-3821 2012.
2012 Igari A, Nakagawa T, Moriki T, Yamaguchi Y, Matsumoto M, Fujimura Y, Soejima K, Murata M: Identification of epitopes on ADAMTS13 recognized by a panel of monoclonal antibodies with functional or non-functional effects on catalytic activity. Thromb Res 130(3)pp.79-83 2012.
2012 Yamaguchi Y, Abe T, Sato Y, Matsubara Y, Moriki T, Murata M: Effects of VerifyNow P2Y12 test and CYP2C19*2 testing on clinical outcomes of patients with cardiovascular disease: A systematic review and meta-analysis. Platelets. 2012.
2012 Koyama Y, Homma K, Miwa M, Ikeda K, Murata M, Hasegawa T: Measurement of reference intervals for urinary free adrenal steroid levels in Japanese newborn infants by using stable isotope dilution gas chromatography/mass spectrometry. Clin Chim Acta. 415C:302-305 2012.
2012 Arai T, Kawamura A, Matsubara Y, Yokoyama K, Ikeda Y, Fukuda K, Murata M: Effect of chronic kidney disease on platelet reactivity to dual-antiplatelet therapy in patientstreated with drug-eluting stents. Heart Vessels. Vol.27,No.5 pp.480-485. 2012.
2012 okoyama K, Murata M, Ikeda Y, Okamoto S: Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma. Thromb Res. 130(1)pp.7-11 2012.
2012 Koyama Y, Homma K, Fukami M, Miwa M, Ikeda K, Ogata T, Hasegawa T, Murata M: Two-step biochemical differential diagnosis of classic 21-hydroxylase deficiency and cytochrome P450 oxidoreductase deficiency in Japanese infants by GC-MS measurement of urinary pregnanetriolone/ tetrahydroxycortisone ratio and 11β-hydroxyandrosterone. Clin Chem. Vol.58,No.4 pp.741-747 2012.
2012 Yamazaki H, Chijiwa T, Inoue Y, Abe Y, Suemizu H, Kawai K, Wakui M, Furukawa D, Mukai M, Kuwao S, Saegusa M, Nakamura M: Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene. Exp Ther Med. Vol. 3 No. 5 pp. 793-796 2012.
2011 Yamaguchi Y, Moriki T, Igari A, Nakagawa T, Wada H, Matsumoto M, Fujimura Y, Murata M: Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura. Thrombosis Research Vol.128 pp.169-173 2011.
2011 Kurata Y, Fujimura K, Kuwana M, Tomiyama Y, Murata M: Epidemiology of primary immune thrombocytopenia in children and adults in Japan : a population-based stuby and literature review. Int J Hematol Vol93 pp.329-335 2011.
2011 Morikawa T, Murata M, Okuda S, Tsuruta H, Iwanaga S, Murata M, Satoh T, Ogawa S, Fukuda K: Quantitative analysis of right ventricular function in patients with pulmonary hypertension using three-dimensional echocardiography and a two-dimensional summation method compared to magnetic resonance imaging. Am J Cardiol.   Vol.107,No.3 pp.484-489 2011.
2011 Mori T, Nakamura Y, Kato J, Sugita K, Murata M, Kamei K, Okamoto S: Fungemia due to Rhodotorula mucilaginosa after allpgeneic hematopoietic stem cell transplantation. Transplant Infectious Disease Vo.14 pp.91-94 2011.
2011 Fujimura Y, Matsumoto M, Isonishi A, Yagi H, Kokame K, Soejima K, Murata M, Miyata T: Natural history of Upshaw-schlman syndrome based on ADAMTS13 gene aualysis in Japan. Journal of Thrombosis and Haemostasis. Vol.9,No.1 pp.283-301 2011.
2011 Ono M, Matsubara Y, Shibano T, Ikeda Y, Murata M: GSK-3βnegatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro. Platelets Vol.22,No.3 pp.196-203 2011.
2011 Obara H, Aikawa N, Hasegawa N, Hori S, Ikeda Y, Kobayashi Y, Murata M, Okamoto S, Takeda J, Tanabe M, Sakakura Y, Ginba H, Kitajima M, Kitagawa Y: The role of a real-time PCR technology for rapid detection and identification of bacterial and fungal pathogens in whole-blood samples. J Infect Chemother. 17(3) pp.327-333 2011.
2011 Hasegawa M, Kawai K, Mitsui T, Taniguchi K, Monnaoi M, Wakui M, Ito M, Suematsu M, Peltz G, Nakamura M, Suemizu1 M: The reconstituted ‘humanized liver’ in TK-NOG mice is mature and functional. Biochem. Biophys. Res. Commun. Vol. 405 No. 3 pp. 405-410 2011.
2011 Hayasaka T, Goto-Inoue N, Ushijima M, Yao I, Yuba-Kubo A, Wakui M, Shigeki Kajihara S, Matsuura M, Setou M: Development of imaging mass spectrometry (IMS) dataset extract software, IMS convolution. Anal. Bioanal. Chem. Vol. 401 No. 1 pp. 183-193 2011.
2011 Kubo A, Ohmura M, Wakui M, Takeshita K, Harad T, Kajihara S, Ogawa K, Suemizu H, Nakamura M, Setou M, Suematsu M: Semi-quantitative analyses of metabolic systems of human colon cancer metastatic xenografts in livers of superimmunodeficient NOG mice. Anal. Bioanal. Chem. Vol. 400 No. 7 pp. 1895-1904 2011.
2011 Yamauchi Y, Izumi Y, Asakura K, Fukutomi T, Serizawa A, Kawai K, Wakui M, Suematsu M, Nomori H: Lovastatin and valproic acid additively attenuate cell invasion in ACC-MESO-1 cells. Biochem. Biophys. Res. Commun. Vol. 410 No. 2 pp. 328-332 2011.
2011 Asakura K, Izumi Y, Yamamoto M, Yamauchi Y, Kawai K, Serizawa A, Mizushima, T, Ohmura M, Kawamura M, Wakui M, Adachi T, Nakamura M, Suematsu M, Nomori H: The cytostatic effects of lovastatin on ACC-MESO-1 cells. J. Surg. Res. Vol. 170 No. 2 pp. e197-209, 2011.
2011 Ono Y, Kawachi S, Hayashida T, Wakui M, Tanabe M, Itano O, Obara H, Shinoda M, Hibi T, Oshima G, Tani N, Mihara K, Kitagawa Y: The influence of donor age on liver regeneration and hepatic progenitor cell populations. Surgery. Vol. 150 No. 2 pp. 154-161, 2011.
2011 Nagai T, Kohsaka S, Murata M, Okuda S, Anzai T, Sato T, Fukuda K:Significance of electrocardiographic right ventricular hypertrophy in patients with pulmonary hypertension or without right ventricular dysfunction. J Am Coll Cardiol. 57: E149. 2011.
2011 Egashira T, Murata M, Yasuda R, Suzuki K, Tsuruta H, Akaiashi M, Fukuda K:Three-dimensional echocardiography findings of biventricular thrombi complicated by cerebral embolism. J Echocardiography. 9: 163-164  2011.
2011 Shinmura K, Tamaki K, Sano M, Murata M, Yamakawa H, Fukuda K. Impact of caloric restriction on cardiac senescence:Caloric restriction ameliorates cardiac diastolic dysfunction associated with aging. J Mol Cell Cardiol. 50: 117-127. 2011.
2011 Matsubara Y, Suzuki H, Ikeda Y, Murata M: Generation of megakaryocytes and platelets from preadipocyte cell line 3T3-L1, but not the parent cell line 3T3, in vitro. Biochem Biophys Res Commun Vol.402,No.4 pp.796-800 2011.
2010 Yanagihara K, Kitagawa Y, Tomonaga M, Tsukasaki K, Kohno S, Seki M, Sugimoto H, Shimazu T, Tasaki O, Matsushima A, Ikeda Y, Okamoto S, Aikawa N, Hori S, Obara H, Ishizaka A, Hasegawa N, Takeda J, Kamihira S, Sugahara K, Asari S, Murata M, Kobayashi Y, Ginba H, Sumiyama Y, Kitajima M: Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection Kit. Critical Care Vol.14,NoR.159 pp.1-9 2010.
2010 Masahiro M, Wakui M, Monnai M, Mizushima T, Nishime C, Kawai K, Ohmura M, Suemizu H, Hishiki T, Suematsu M, Murata M, Chijiwa T, Furukawa D, Ogoshi K, Makuuchi H and Nakamura M: Reduced CD73 Expression and its association with altered purine nucleotide metabolism in colorectal cancer cells robustly causing liver metastases. ONCOLOGY LETTERS Vol.1 pp.431-436 2010.
2010 Teramoto T, Shimada K, Uchiyama S, Sugawara M, Goto Y, Yamada N, Oikawa S, Ando K, Ishizuka N, Yamazaki T, Yokoyama K, Murata M, Ikeda Y: Raionale,desing,and baseline data of the Japanese Primary Prevention Project(JPPP)-A randomized,open-ladel,contorlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events. Am Heart J Vol.159,No.3 pp.361-369 2010.
2010 Ochi Y, Suzuki M, Imaoka T, Murata M, Nishihara H, Einaga Y, Yamamoto K: Controlled storage of ferrocene derivatives as redox-active molecules in dendrimers. J Am Chem 132(14) pp.5061-5069 2010.
2010 Moriki T, Maruyama IN, Igari A, Ikeda Y, Murata M: Identification of ADAMTS13 peptide sequences binding to von Willebrand factor. Biochem Biophys Res Commun Vol.391,No.1 pp.783-788 2010.
2010 Kato J, Mori T, Sugita K, Murata M, Ono Y, Yamane A, Shimizu T, Okamoto S: Central line-associated bacteremia caused by drug-resistant Staphylococcus caprae after chemotherapy for acute myelogenous leukemia. Int J Hematol Vol.91,No.5 pp.912-913 2010.
2010 Ito N, Wada H, Matsumoto M, Fujimura Y, Murata M, Izuno T, Sugita M, Ikeda Y: A second national questionnaire survey of TMA. Int J Hematol Vol.92,No.1 pp.68-75 2010.
2010 Handa K, Ohmura M, Nishime C, Hishiki T, Nagahata Y, Kawai K, Suemizu H, Nakamura M, Wakui M, Kitagawa Y, Suematsu M, Tsukada K: Phosphorescence-assisted microvascular O2 measurements reveal alterations of oxygen demand in human metastatic colon cancer in the liver of superimmunodeficient NOG mice. Adv. Exp. Med. Biol. Vol. 662 pp.423-429 2010.
2010 Yuasa S, Onizuka T, Shimoji K, Ohno Y, Kageyama T, Yoon SH, Egashira T, Seki T, Hasimoto H, Nishiyama T, Kaneda R, Murata M, Hattori F, Makino S, Sano M, Ogawa S, WJ Prall O, Harvey RP, Fukuda K:Zac1 is an essential transcription factor for cardiac morphogenesis. Circ Res. 106: 1083-1091.  2010.
2010 Murata M, Tohyama S, Fukuda K. The impact of recent advances in cardiovascular regenerative medicine on clinical therapeutics and drug discovery. Pharmacology & Therapeutics 126: 109-118. 2010.
2010 Neely GG, Kuba K, Cammarato A, Isobe K, Amann S, Zhang L, Murata M, Elmén L, Gupta V, Arora S, Sarangi R, Dan D, Fujisawa S, Usami T, Xia CP, Keene AC, Alayari KN, Yamakawa H, Elling U, Berger C, Novatchkova M, Koglgruber R, Fukuda K, Nishina H, Isobe M, Pospisilik JA, Imai Y, Pfeufer A, Hicks AA, Pramstaller PP, Subramaniam S, Kimura A, Ocorr K, Bodmer R, Penninger JM:A novel in vivo Drosophia RNAi screen identifies NOT3 as a conserved regulator of heart function. Cell 106: 142-153. 2010.
2010 Hattori F, Chen H, Yamashita H, Tohyama S, Satoh Y, Yuasa S, Li W, Yamakawa H, Tanaka T, Onitsuka T, Shimoji K, Ohno Y, Egashira T, Kaneda R, Murata M, Hidaka K, Morisaki T, Sasaki E, Suzuki T, Sano M, Makino S, Oikawa S, Fukuda K:A non-genetic method for purifying stem cell-derived cardiomyocytes. Nature Methods 7: 61-66. 2010.
2009 Motoda H, Murata M, Iwanaga S, Matsushita K, Nakamizo H, Wakino S, Murata M, Ogawa S: Parachute mitral valve incidentally diagnosed in an adult patient with hypertension. J Echocardiography. 2009.
2009 Matsubara Y, Suzuki H, Ikeda Y, Murata M: Generation of megakaryocytes and platelets from human subcutaneous adipose tissues. Biochem Biophys Res Commun Vol.378,No.4 pp.716-720 2009.
2009 Homma K, Hida M, Ikeda K, Yamaga N, Murata M, Hasegawa T: Measurement of Serum 17α-hidroxyprogesterone in Newborn Infants by Stable Dilution- Gas Chromatography/Mass Spectrometry. Clinical Pediatric Endocrinology Vol.18,No.3  pp.77-80 2009.
2009 Ishikawa J, Okada H, Kato H, Takeshita S, Honda S, Kawasaki T, Suehisa E, Tsuji H, Madoiwa S, Sakata Y, Kojima T, Murata M, Ikeda Y, Kokubo Y, Okamura T, Tomoike H, Miyata T: Association of Asn221Ser mutation in tissue factor pathway inhibitor-beta with plasma total tissue factor pathway inhibitor level. Blood Coagul Fibrinolysis Vol.20,No.1 pp.22-26 2009.
2009 Fujimura Y, Matsumoto M, Kokame K, Isonishi A, Soejima K, Akiyama N, Tomiyama J, Natori K, Kuranishi Y, Imamura Y, Inoue N, Higasa S, Seike M, Kozuka T, Hara M, Wada H, Murata M, Ikeda Y, Miyata T, George JN: Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. Br J Haematol Vol.144,No.5 pp.742-754 2009.
2009 Katayama T, Murata M, Iwanaga S, Kawamura A, Yoshikawa T, Ogawa S: Left ventricular pseudoaneurysm with peculiar coronary artery collapse. J Am Coll Cardiol  Vol. 53 No. 19 pp. 1823 2009.
2009 Ito N, Wada H, Matsumoto M, Fujimura Y, Murata M, Izuno T, Sugita M, Ikeda Y: National questionnaire survey of TMA. Int J Hematol Vol.90, No. 3 pp. 328-335 2009.
2009 Chijiwa T, Abe Y, Ikoma N, Yamazaki H, Tsukamoto H, Suemizu H, Kawai K, Wakui M, Nishime C, Matsumoto H, Matsuyama M, Mukai M, Ueyama Y, Nakamura M: Thrombospondin 2 inhibits metastasis of human malignant melanoma through microenvironment-modification in NOD/SCID/gCnull (NOG) mice. Int. J. Oncol. Vol.34 No. 1 pp. 5-13 2009.
2009 Harada T, Yuba-Kubo A, Sugiura Y, Zaima N, Hayasaka T, Goto-Inoue N, Wakui M, Suematsu M, Takeshita K, Ogawa K, Yoshida Y, Setou M: Visualization of volatile substances in different organelles with an atmospheric-pressure Mass Microscope. Anal. Chem. Vol. 81 No. 21 pp. 9153-9157 2009.
2009 Suzuki R, Hattori F, Itabashi Y, Yoshioka M, Yuasa S, Manabe-Kawaguchi H, Murata M, Makino S, Kokaji K, Yozu R, Fukuda K:Omentopexy enhances graft function in myocardial cell sheet transplantation. Biochem Biophys Res Commun. Vol. 387: pp.353-359  2009.
2009 Tanaka T, Tohyama S, Murata M, Nomura F, Kaneko T, Chen H, Hattori F, Egashira T, Seki T, Ohno Y, Koshimizu U, Yuasa S, Ogawa S, Yamanaka S, Yasuda K, Fukuda K:In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochem Biophys Res Commun Vol.385 pp.497-502  2009.
2009 Tokudome S, Sano M, Shinmura K, Matsuhashi T, Morizane S, Moriyama H, Tamaki K, Nakanishi H, Yoshikawa N, Shimizu N, Endo J, Katayama T, Murata M, Yuasa S, Kaneda R, Tomita K, Eguchi N, Urade Y, Asano K, Utsunomiya Y, Suzuki T, Taguchi R, Tanaka H, Fukuda K:Glucocorticoid protects heart from ischemia-reperfusion injury through activation of lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis. J Clin Invest. Vol.119 pp.1477-1488.  2009.
2009 Hyodo M, Makino S, Awaji Y, Sakurada Y, Ohkubo T, Murata M, Fukuda K, Tsuda M:A novel in vitro system for cardiomyocyte differentiation with embryonic cells of the medaka (Oryzias latipes). Int J Dev Biol. Vol.53 pp.615-622.  2009.
2009 Shinoda H, Tasaka S, Fujishima S, Yamasawa W, Miyamoto K, Nakano Y, Kamata H, Hasegawa N, Ishizaka A: Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis.  Respiration Vol.78,No.3 pp.285-292. 2009.
2009 Tasaka S, Hasegawa N, Nishimura T, Yamasawa W, Kamata H, Shinoda H, Kimizuka Y, Fujiwara H, Hirose H, Ishizaka A: Elevated Serum Adiponectin Level in Patients with Mycobacterium avium-intracellulare Complex Pulmonary Disease.  Respiration. 2009.
2009 Shimizu M, Hasegawa N, Nishimura T, Endo Y, Shiraishi Y, Yamasawa W, Koh H, Tasaka S, Shimada H, Nakano Y, Fujishima S, Yamaguchi K, Ishizaka A: Effects of tumor necrosis factor-a converting enzyme inhibition on acute lung injury induced by endotoxin in the rat.  Shock. 2009.
2008 Takahashi S, Ushida M, Komine R, Shimodaira A, Uchida T, Ishihara H, Shibano T, Watanabe G, Ikeda Y, Murata M: Platelet responsiveness to in vitro aspirin is independent of COX-1 and COX-2 protein levels and polymorphisms. Thrombosis Research. Vol.121,No.4 pp.509-517 2008.
2008 Matsubara Y, Murata M, Watanabe G, Ikeda Y: Enhancing effect of the (145)Met-allele of GPIb alpha on platelet sensitivity to aspirin under high-shear conditions. Thrombosis Research Vol.123,No.2 pp.331-335 2008.
2008 Yabe M, Matsubara Y, Takahashi S, Ishihara H, Shibano T, Watanabe G, Murata M, Ikeda Y: Alpha 2A adrenergic receptor polymorphism is associated with plasma von Willebrand factor levels in a general population. Blood Coagul Fibrinolysis. 19(5) pp.395-399 2008.
2008 Higashi T, Wakui M, Nakano K, Hashimoto K, Takagi R, Tanaka Y, Matsushita S: Evaluation of adjuvant activities using human antigen presenting cells in vitro. Allergol. Int. Vol.57 No.3 pp.219-222 2008.
2008 Suemizu H, Hasegawa M, KawaiK, Taniguchi K, Monnai M, Wakui M, Suematsu M, Ito M, Peltz G, Nakamura M:Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice. Biochem. Biophys. Res. Commun. Vol.377 pp.248-252 2008.
2008 Murata M, Iwanaga S, Tamura Y, Kondo M, Kouyama K, Murata M, Ogawa S:A real-time 3-dimensional echocardiographic quantitative analysis of left atrial function in left ventricular diastolic dysfunction. Am J Cardiol. Vol.102 pp.1097-1102. 2008.
2008 Chen H, Hattori F, Murata M, Li W, Yuasa S, Onitsuka T, Shimoji K, Ohno Y, Sasaki E, Kimura K, Hakuno D, Sano M, Makino S, Ogawa S, Fukuda K:Common marmoset embryonic stem cell can differentiate into cardiomyocytes. Biochem Biophys Res Commun. Vol.369 pp.801-806.  2008.
2008 Saito F, Tasaka S, Inoue K, Miyamoto K, Nakano Y, Ogawa Y, Yamada W, Shiraishi Y, Hasegawa N, Fujishima S, Takano H, Ishizaka A: Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice.  Am J Respir Cell Mol Biol pp.11-10. 2008.
2008 Zhang H, Tasaka S, Shiraishi Y, Fukunaga K, Yamada W, Seki H, Ogawa Y, Miyamoto K, Nakano Y, Hasegawa N, Miyasho T, Maruyama I, Ishizaka A: Role of Soluble Receptor for Advanced Glycation End-Products on Endotoxin-Induced Lung Injury.  Am J Respir Crit Care Med Vol.178,No.4. 2008.
2008 Yamada W, S Tasaka S, Koh H, Shimizu M, Ogawa Y, Hasegawa N, Miyasho T, Yamaguchi K, Ishizaka A: Role of toll-like receptor 4 in acute neutrophilic lung inflammation induced by intratracheal bacterial products in mice.  Journal of Inflammation Research Vol.1 pp.1-10. 2008.
2007 Yada H, Murata M, Shimoda K, Yuasa S, Kawaguchi H, Ieda M, Adachi T, Murata M, Ogawa S, Fukuda K: Dominant negative suppression of Rad leads to QT prolongation and causes ventricular arrhythmias via modulation of L-type Ca2+ channels in the heart. Circulation Research Vol.101,No.1 pp.69-77 2007.
2007 Yin T, Takeshita S, Sato Y, Sakata T, Shin Y, Honda S, Kawasaki T, Tsuji H, Kojima T, Madoiwa S, Sakata Y, Murata M, Ikeda Y, Miyata T: A large deletion of the PROS1 gene in a deep vein thrombosis patient with protein S deficiency. Thromb Haemost Vol.98,No.4 pp.783-789 2007.
2007 Wakui M, Nakano K, Matsushita S: Notch ligand mRNA levels of human APCs predict Th1/Th2-promoting activities. Biochem. Biophys. Res. Commun. Vol.358 No.2 pp.596-601 2007.
2007 Hagiwara Y, Miyoshi S, Fukuda K, Nishiyama N, Ikegami Y, Tanimoto K, Murata M, Takahashi E, Shimoda K, Hirano T, Mitamura H, Ogawa S. SHP2-mediated signaling cascade through gp130 is essential for LIF-ICa,L, [Ca2+]i transient and APD increase in cardiomyocytes. J Mol Cell Cardiol. Vol.43 pp. 710-716. 2007.
2007 Cingolani E, Ramirez Correa GA, Kizana E, Murata M, Cho HC, Marbán E:Gene therapy to inhibit the calcium channel beta subunit. Physiological consequences and pathophysiological effects in models of cardiac hypertrophy. Circ Res. Vol. 101 pp.167-175.  2007.
2007 Tomita Y, Makino S, Hakuno D, Hattan N, Kimura K, Miyoshi S, Murata M, Ieda M, Fukuda K:Application of mesenchymal stem cell-derived cardiomyocytes as bio-pacemakers: current status and problems to be solved. Med Biol Eng Comput. Vol.45 pp.209-220.  2007.
2006 Nishida H, Murata M, Miyaki K, Omae K, Watanabe K, Ikeda Y: Gorog Thrombosis Test: analysis of factors influencing occlusive thrombus formation. Blood Coagul Fibrinolysis Vol.17,No.3 pp.203-207  2006.
2006 Hattori H, Sato H, Ito D, Tanahashi N, Murata M, Saito I, Watanabe K, Suzuki N: A561C polymorphism of E-selectin is associated with ischemic cerebrovascular disease in the Japanese population without diabetes mellitus and hypercholesterolemia. Brain Res Vol.1108,No.1 pp.221-223 2006.
2006 Takahashi S, Ushida M, Komine R, Shimizu A, Uchida T, Ishihara H, Shibano T, Watanabe G, Ikeda Y, Murata M: Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin. Thromb Res Vol.119,No.4 pp.517-524 2006.
2006 Kimura R, Honda S, Kawasaki T, Tsuji H, Madoiwa S, Sakata Y, Kojima T, Murata M, Nishigami K, Chiku M, Hayashi T, Kokudo Y, Okayama A, Tomoike H, Ikeda Y, Miyata T: ProteinS‐K196E mutation as a genetic risk factor for deep vein thrombosis. BLOOD Vol.107,No.4 pp.1737-1738 2006.
2006 Hattori H, Sonoda A, Sato H, Ito D, Tnahashi N, Murata M, Saito I, Watanabe K, Suzuki N: G501C polymorphism of oxidized LDL receptor gene (OLR1) and ischemic stroke. Brain Res Vol.1121,No.1 pp.246-249 2006.
2006 Tsukamoto H, Hirose H, Dan K, Ishii K, Kikuchi H, Murata M: Apolipoprotein E deficiency associated with type III hyperlipoproteinemia--analysis of apolipoprotein E. Rinsho Byori 54(2) pp.121-125 2006.
2006 Matsubara Y, Murata M, Yoshida T, Watanabe K, Saito I, Miyaki K, Omae K, Ikeda Y: Telomere length of normal leukocytes is affected by a functional polymorphism of hTERT. Biochemical and Biophysical Research Communications Vol.341 pp.128-131. 2006.
2006 Matsubara Y, Murata M, Watanabe K, Saito I, Miyaki K, Omae K, Ishikawa M, Matsushita K, Iwanaga S, Ogawa S, Ikeda Y: Coronary artery disease and a functional polymorphism of hTERT. Biochem Biophys Res Commun Vol.348,No.2 pp.662-672 2006.
2006 Yabe M, Matsubara Y, Takahashi S, Ishihara H, Shibano T, Miyaki K, Omae K, Watanabe G, Murata M, Ikeda Y: Identification of ADRA2A polymorphisms related to shear-mediated platelet function. Biochem Biophys Res Commun Vol.347, No.4 pp.1001-1005 2006.
2006 Arrell DK, Elliott ST, Kane LA, Guo Y, Pedersen PL, Robinson J, Murata M, Murphy AM, Marbán E, Van Eyk JE:Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ Res. Vol.99 pp.706-714. 2006.
2005 Miyaki K, Sutani S, Kikuchi H, Takei I, Murata M, Watanabe K, Omae K: Increased Risk of Obesity Resulting from the Interaction between High Energy Intake and the Trp64Arg Polymorphism of the β3-adrenergic Receptor Gene in Healthy Japanese Men. J Epdemiol Vol.15,No.6 pp.203-210 2005.
2005 Miyaki K, Murata M, Kikuchi H, Takei I, Nakayama T, Watanabe K, Omae K: Assessment of tailor-made prevention of atherosclerosis with folic acid supplementation: randomized, double-blind, placebo-controlled trials in each MTHFR C677T genotype. J Hum Genet Vol.50 pp.241-248 2005.
2005 Isshiki I, Favier R, Moriki T, Uchida T, Ishihara H, Van Dreden P, Murata M, Ikeda Y: Genetic analysis of hereditary factor X deficiency in a French patient of Sri Lankan ancestry: in vitro expression study identified Gly366Ser substitution as the molecular basis of the dysfunctional factor X. Blood Coagulation and Fibrinolysis Vol.16 pp.9-16 2005.
2005 Miyaki K, Tohyama S, Murata M, Kikuchi H, Takei I, Watanabe K, Omae K: Salt Intake Affects the Relation Between Hypertension and the T-786C Polymorphism in the Endothelial Nitric Oxide Synthase Gene. American Journal of Hypertension Vol.18,No 12 pp.1556-1562 2005.
2005 Hattori H, Ito D, Tanahashi N, Murata M, Saito I, Watanabe K, Suzuki N: T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease. Neuroscience Letters pp.132-135 2005.
2005 Matsubara Y, Murata M, Hayashi T, Suzuki K, Okamura Y, Handa M, Ishihara H, Shibano T, Ikeda Y: Platelet glycoprotein Ib alpha polymorphisms affect the interaction with von Willebrand factor under flow conditions. British Journal of Haematology Vol.128 pp.533-539 2005.
2005 Oguchi S, Ishii K, Moriki T, Takeshita E, Murata M, Ikeda Y, Watanabe K: Factor XII Shizuoka, a novel mutation (Ala392Thr) identified and characterized in a patient with congenital coagulation factor XII deficiency. Thrombosis Research Vol.115,No.3 pp.191-197 2005.
2005 Miyoshi S, Mitamura H, Fukuda Y, Tanimoto K, Hagiwara Y, Kanki H, Takatsuki S, Murata M, Miyazaki T, Ogawa S: Link between SCN5A mutation and the Brugada syndrome ECG phenotype: simulation study. Circ J 69(5) pp.567-575 2005.
2005 Wakui M, Morel L, Butfiloski EJ, Kim C, Sobel ES: Genetic dissection of SLE pathogenesis: partial functional complementation between Sle1 and Sle3/5 demonstrates requirement for intracellular co-expression for full phenotypic expression of lupus. J. Immunol. Vol.175No.2 pp.1337-1345 2005.
2005 Hattan N, Kawaguchi H, Ando K, Kuwabara E, Fujita J, Murata M, Suematsu M, Mori H, Fukuda K:Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. Cardiovasc Res. Vol.65 pp.334-344. 2005.
2004 Miyaki K, Omae K, Murata M, Tanahashi N, Saito I, Watanabe K: High throughput multiple combination extraction from large scale polymorphism data by Exact Tree Method. J Hum Genetics pp.455-462 2004.
2004 Murata M, Maruyama T, Suzuki Y, Saruta T, Ikeda Y: Paraoxonase 1 Gln/Arg polymorphism is associated with the risk of microangiopathy in Type 2 diabetes mellitus. Diabetic Medicine Vol.21,No.8 pp.837-844 2004.
2004 Uchida T, Wada H, Mizutani M, Iwashita M, Ishihara H, Shibano T, Suzuki M, Matsubara Y, Soejima K, Matsumoto M, Fujimura Y, Ikeda Y, Murata M: Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura. Blood Vol.104,No.7 pp.2081-2083 2004.
2004 Azuma K,Oguchi S,Matsubara M,Mamizuka T,Murata M,Kikuchi H,Watanabe K,Katsukawa F,Yamazaki H, Shimada A,Saruta T: Novel resistin polymorphisms: Association with serum resistin level in Japanese obese individuals. Horm Metab Res 2004.
2004 Ishii K, Oguchi S, Moriki T, Yatabe Y, Takeshita E, Murata M, Ikeda Y, Watanabe K: Genetic analyses and expression studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor XII deficiency. Blood Coagulation and Fibrinolysis Vol.15 pp.367-373 2004.
2004 Suzuki M, Murata M, Matsubara Y, Uchida T, Ishihara H, Shibano T, Ashida S, Soejima K, Okada Y, Ikeda Y: Detection of von Willebrand factor - cleaving protease (ADAMTS-13) in human platelets. Biochem Biophys Res Commun Vol.313,No.1 pp.212-216 2004.
2004 Matsunaga S, Maruyama T, Yamamoto Y, Motohashi Y, Hirose H, Shimada A, Murata M, Saruta T: Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care Vol.27,No.2 pp.303-307 2004.
2004 Motohashi Y, Maruyama T, Murata M, Nakano S, Maruyama C, Kyotani S, Tsushima M, Saruta T: Role of genetic factors (CETP gene Taq IB polymorphism and Apo A-1 gene MSP I polymorphism) in serum HDL-C levels in women. Nutr Metab Cardiovasc Dis Vol.14,No.1 pp.6-14 2004.
2004 Wakui M, Kim J, Butfiloski EJ, Morel L, Sobel ES:Genetic dissection of lupus pathogenesis: Sle3/5 impacts IgH CDR3 sequences, somatic mutations, and receptor editing. J. Immunol. Vol.173,No12 pp.7368-7376 2004.
2004 Murata M, Cingolani E, McDonald AD, Donahue JK, Marbán E:Creation of a genetic calcium channel blocker by targeted Gem gene transfer in the heart. Circ Res. Vol.95 pp.398-405.  2004.
2004 Takahashi E, Fukuda K, Miyoshi S, Murata M, Kato T, Ita M, Tanabe T, Ogawa S:Leukemia inhibitory factor activates cardiac L-Type Ca2+ channels via phosphorylation of serine 1829 in the rabbit Cav1.2 subunit. Circ Res. Vol.94 pp.1242-1248.  2004.
2004 Azuma K. Oguchi S. Matsubara Y. Mamizuka T. Murata M. Kikuchi H. Watanabe K. Katsukawa F. Yamazaki H. Shimada A. Saruta T: Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. Horm Metab Res Vol.36 pp.564-570 2004.
2003 Watanabe R, Ishibashi T, Saitoh Y, Shichishima T, Maruyama Y, Enomoto Y, Handa M, Oda A, Ambo H, Murata M, Ikeda Y: Bernard-Soulier syndrome with a homozygous 13 base pair deletion in the signal peptide-coding region of the platelet glycoprotein Ibβ gene. Blood Coagulation and Fibrinolysis Vol.14,No.4 pp.387-394. 2003.
2003 Matsubara Y, Murata M, Sugita K., Ikeda Y: Identification of a novel point mutation in platelet glycoprotein Ibα, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease. Journal of Thrombosis and Haemostasis Vol.1,No.10 pp.2198-2205 2003.
2003 Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, Saruta T: Correlation between serum resistin level and adiposity in obese individuals. Obesity Research Vol.11,No.8 pp.997-1001 2003.
2003 Sagawa M, Takao M, Nogawa S, Mizuno M, Murata M, Amano T, Koto A: Wilson's disease associated with olfactory paranoid syndrome and idiopathic thrombocytopenic purpura. No To Shinkei Vol.55,No.10 pp.899-902 2003.
2003 Nakanishi M, Takanami Y, Maruyama T, Murata M, Motohashi Y, Nakano S, Uchida K, Maruyama C, Kyotani S, Tsushima M: The ratio of serum paraoxonase/arylesterase activity using an improved assay for arylesterase activity to discriminate PON1 (R192) from PON1 (Q192). Journal of Atherosclerosis and Thrombosis. Vol.10,No.6 pp.337-342 2003.
2003 Murata M, Sasaki N, Guo Y, Jo SH, Ohler A, Akao M, O'Rourke B, Xiao RP, Bolli R, Marbán E:MCC-134, a single pharmacophore, opens surface ATP-sensitive potassium channels, blocks mitochondrial ATP-sensitive potassium channels, and suppresses preconditioning. Circulation. Vol.107 pp.1183-1188. 2003.
2003 Hirano Y, Yoshinaga T, Murata M, Hiraoka M:Prepulse-induced mode 2 gating behavior with and without beta-adrenergic stimulation in cardiac L-type Ca channels. Am J Physiol. Vol.276 pp.C1338-1345. 2003.
2003 Tasaka S, Ishizaka A, Yamada W, Shimizu M, Koh H, Hasegawa N, Adachi Y, Yamaguchi K: Effect of CD14 blockade on endotoxin-induced acute lung injury in mice. American journal of respiratory cell molecular biology Vol.29,No.2 pp.252-258. 2003.
2003 Watanabe N, Nakajima H, Suzuki H, Oda Ai, Matsubara Y, Moroi M, Terauchi Y,   Kadowaki T, Suzuki H, Koyasu S, Ikeda Y, Handa M: Functional phenotype of phosphoinositide 3-kinase p85α-null platelets characterized by an impaired response to GP VI stimulation. Blood Vol.102,No.2 pp.541-548 2003.
2002 Ito D, Tanahashi N, Murata M, Sato H, Saito I, Watanabe K, Fukuuchi Y: Notch3 gene polymorphism and ischaemic cerebrovascular disease. J Neurol Neurosurg Psychiatry 72(3) pp.382-384. 2002.
2002 Kawano K, Yoshino H, Aoki N, Udagawa H, Watanuki A, Hioki Y, Hasumura Y, Yasumura T, Homori M, Murata M, Ikeda Y, Ishikawa K: Shear-induced platelet aggregation increases in patients with proximal and severe coronary artery stenosis. Clinical cardiology Vol.25,No.4 pp.154-160. 2002.
2002 Matsubara Y, Murata M, Moriki T, Yokoyama K, Watanabe N, Nakajima H, Handa M, Kawano K, Aoki N, Yoshino H, Ikeda Y: A novel polymorphism, 70Leu/Phe, disrupts a consensus leu residue within the leucine-rich repeat sequence of platelet glycoprotein Ibα. Thrombosis and haemostasis Vol.87,No5 pp.867-872. 2002.
2002 Nishiya T, Kainoh M, Murata M, Handa M, Ikeda Y: Reconstitution of adhesive properties of human platelets in liposomes carrying both recombinant glycoproteins Ia / IIa and Ibα under flow conditions:specific synergy of receptor-ligand interactions. Blood Vol.100,No.1 pp.136-142. 2002.